Evidence map›Paper›PMID 42444943›Full record

ReviewJournal of thoracic disease2026

Evolution and refinements in minimally invasive esophagectomy: a narrative review.

Emma Jacobs, Hiran C Fernando

Abstract readReview
In one paragraph

Review in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Emma JacobsDepartment of Surgery, Allegheny Health Network, Pittsburgh, PA, USA.
Hiran C FernandoMcGinnis Thoracic and Cardiovascular Associates, Forbes Hospital, Allegheny Health Network, Monroeville, PA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objective: Morbidity from traditional open esophagectomies has led to the development and growth of the minimally invasive approach. As this technique has become more widely used over the last few decades, a better understanding of its utility and its effect on patient outcomes continues to take shape. The aim of this narrative review is to discuss how minimally invasive esophagectomy (MIE) has developed as a technique, how patient outcomes have changed over time, and what progress is currently being made in the perioperative adjuncts to improve patient outcomes. Methods: A search was conducted using PubMed and Google Scholar to identify studies pertaining to the advancement of MIE. No restriction was placed on a particular time frame given the historical aspect of the review. Emphasis was placed on randomized controlled trials, prospective studies, meta-analyses and systematic reviews performed within the past 10 years for discussion regarding recent developments and updates in the field. Key Content and Findings: MIE has been key in reducing pulmonary morbidity and overall post-operative complication rates compared to open esophagectomy (OE). The development of robotic-assisted minimally invasive esophagectomy (R-MIE) shows promise in improving oncologic outcomes by attaining greater lymph node yield. However, success of these procedures is associated with a learning curve that can be a barrier to achieving these outcomes and is difficult to overcome in low-volume centers. Additional interventions that can potentially improve the results of MIE include the introduction of enhanced recovery after surgery (ERAS) programs, early nutrition, and gastric preconditioning, which have demonstrated promise in improving outcomes, such as reduced anastomotic leaks, and pulmonary complications, but warrant further randomized studies. Conclusions: MIE has proven beneficial in reducing the morbidity of esophagectomies without compromising the oncologic outcome of patients with esophageal cancer. The introduction of R-MIE offers the possibility of further improving outcomes with greater dexterity and visualization. Nonetheless, the learning curve for such a procedure is steep and is an obstacle in achieving overall favorable patient outcomes. Refinements to the minimally invasive technique are currently in development and show promising evidence in reducing the morbidity of esophagectomies.

Indexed as

anastomotic leakhybrid esophagectomy (HE)Minimally invasive esophagectomy (MIE)robotic-assisted minimally invasive esophagectomy (R-MIE)

Identifiers

PMID42444943
PMCPMC13358825

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.